XIGEN Trademark

Trademark Overview


On Friday, January 6, 2012, a trademark application was filed for XIGEN with the United States Patent and Trademark Office. The USPTO has given the XIGEN trademark a serial number of 85510388. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Xigen S.A.. The XIGEN trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Food supplements for medical purposes; pharmaceutical, veterinary and sanitary preparations, namely, anti-inflammatory drugs, inhibitors of cell signalling, anti-cancer drugs, antiinfectives and anti-viral drugs; dietetic substances adapted for medical use, namely, food for babies; adjuvants for medical purposes; proteins for medical purposes; biological preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; pharmaceutical preparations for medical purposes, namely, for the treat...

Advertising; business management; business administration assistance; providing office functions, providing business analysis and research services

Scientific and technological services and research, namely, pharmaceutical research in particular drug discovery, and design, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; providing pharmaceutical analysis and research services, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; design and development of computer hardware and software
xigen

General Information


Serial Number85510388
Word MarkXIGEN
Filing DateFriday, January 6, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4405437
Registration DateTuesday, September 24, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements


Goods and ServicesFood supplements for medical purposes; pharmaceutical, veterinary and sanitary preparations, namely, anti-inflammatory drugs, inhibitors of cell signalling, anti-cancer drugs, antiinfectives and anti-viral drugs; dietetic substances adapted for medical use, namely, food for babies; adjuvants for medical purposes; proteins for medical purposes; biological preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; pharmaceutical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular and rheumatologic diseases; ferments for pharmaceutical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; hormones for medical purposes; medicinal infusions for medical purposes, namely, for the treatment of inflammatory diseases, for the treatment of inflammatory diseases in the eye or in the gastro-intestinal tract, for the treatment of neurological disorders, for the treatment of dementia, for the treatment of Parkinson's disease, for the treatment of stroke, for the treatment of traumatic brain damage, for the treatment of dry eye, for the treatment of cancer, for the treatment of infections, for the treatment of viral infections, for the treatment of cardiovascular diseases and rheumatologic diseases; chemical reagents for medical or veterinary purposes, excluding anti-viral and HIV pharmaceutical preparations and substances
Goods and ServicesAdvertising; business management; business administration assistance; providing office functions, providing business analysis and research services
Goods and ServicesScientific and technological services and research, namely, pharmaceutical research in particular drug discovery, and design, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; providing pharmaceutical analysis and research services, excluding pharmaceuticals in the HIV and anti-viral therapeutic areas; design and development of computer hardware and software

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXigen S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address1066 Epalinges
CH

Party NameXigen S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address1066 Epalinges
CH

Party NameXigen S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1066 Epalinges
CH

Trademark Events


Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, September 24, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 24, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2013PAPER RECEIVED
Tuesday, August 20, 2013TTAB RELEASE CASE TO TRADEMARKS
Tuesday, August 20, 2013OPPOSITION TERMINATED NO. 999999
Tuesday, August 20, 2013OPPOSITION DISMISSED NO. 999999
Monday, July 29, 2013PAPER RECEIVED
Friday, June 7, 2013OPPOSITION INSTITUTED NO. 999999
Thursday, January 3, 2013EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 5, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 5, 2012AMENDMENT FROM APPLICANT ENTERED
Monday, November 5, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 5, 2012ASSIGNED TO LIE
Thursday, October 25, 2012PAPER RECEIVED
Wednesday, April 18, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 18, 2012NON-FINAL ACTION E-MAILED
Wednesday, April 18, 2012NON-FINAL ACTION WRITTEN
Wednesday, April 11, 2012ASSIGNED TO EXAMINER
Wednesday, January 11, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 10, 2012NEW APPLICATION ENTERED IN TRAM